Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
DB-001 by Direct Biologics for Ulcerative Colitis: Likelihood of Approval
DB-001 is under clinical development by Direct Biologics and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase...
DB-001 by Direct Biologics for Transplant Rejection: Likelihood of Approval
DB-001 is under clinical development by Direct Biologics and currently in Phase III for Transplant Rejection. According to GlobalData, Phase...
DB-001 by Direct Biologics for Acute Respiratory Distress Syndrome: Likelihood of Approval
DB-001 is under clinical development by Direct Biologics and currently in Phase III for Acute Respiratory Distress Syndrome. According to...
DB-001 by Direct Biologics for Crohn's Disease (Regional Enteritis): Likelihood of Approval
DB-001 is under clinical development by Direct Biologics and currently in Phase II for Crohn's Disease (Regional Enteritis). According to...